Immuron LimitedASX: IMC

CEO Address

· Issued by Immuron Limited via ASX

Filed with ASX · · 11 pages · English

Summary by 6ix AI

Immuron Limited has released the CEO Address for its Annual General Meeting, detailing the company's focus on developing targeted polyclonal antibodies for infectious diseases. The address highlights recent financial achievements, including positive revenue trends and ongoing sales growth for its product Travelan®.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX/NASDAQ Announcement 18 November 2026 2026 Annual General Meeting - CEO Address Immuron Limited (ASX: IMC; NASDAQ: IMRN) attaches the CEO Address to be delivered by Chief Executive Officer, Steve Lydeamore, at today’s Annual General Meeting. - - - END - - - COMPANY CONTACT: Steven Lydeamore...

Immuron Limited on 6ix

In the deck

Earlier from Immuron

Later from Immuron

All Immuron news releases